Last news
Biosyngen's Cell Therapy BRG01 Granted Orphan Drug Designation by the U.S. FDA for Treatment of Nasopharyngeal Cancer

Biosyngen's Cell Therapy BRG01 Granted Orphan Drug Designation by the U.S. FDA for Treatment of Nasopharyngeal Cancer

...

Live from ASCO 2023 | Ascentage Pharma Releases Updated Data Showing APG-2449's Potential as a New Treatment for Drug-Resistant NSCLC

Live from ASCO 2023 | Ascentage Pharma Releases Updated Data Showing APG-2449's Potential as a New Treatment for Drug-Resistant NSCLC

...

CGTN: Why does China stick to the path of common prosperity?

CGTN: Why does China stick to the path of common prosperity?

...

IBM to Build its First European Quantum Data Center to Serve Expanding Ecosystem

IBM to Build its First European Quantum Data Center to Serve Expanding Ecosystem

...

Window to the Wild - Meeting marvellous wildlife through Hikvision's video technology

Window to the Wild - Meeting marvellous wildlife through Hikvision's video technology

...

VISION LIFE Accelerates Global Expansion, Announces Major Development Plan at Summer Conference in Tokyo

VISION LIFE Accelerates Global Expansion, Announces Major Development Plan at Summer Conference in Tokyo

...

USANA Malaysia Named Top Combination Dietary Supplements Brand by Euromonitor International

USANA Malaysia Named Top Combination Dietary Supplements Brand by Euromonitor International

...

'Kaigaifx Journal' managed by Media With, inc., announces "Financial Service Provider Awards."

'Kaigaifx Journal' managed by Media With, inc., announces "Financial Service Provider Awards."

...

menu
menu